HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
Non-alcoholic fatty liver disease (NAFLD) is common in individuals with obesity, characterized by fat accumulation in liver cells that can lead to liver inflammation and fibrosis. NAFLD is closely linked to metabolic syndrome and insulin resistance, both of which are prevalent in people with obesity. Managing obesity through a balanced diet, regular exercise, and, in some cases, medications can help reverse fatty liver disease and improve liver function. Weight loss of just 5-10% has been shown to significantly reduce liver fat and inflammation, highlighting the importance of effective obesity management in preventing liver-related complications.
